The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals.
IDT Australia Limited announced that the U.S. Food and Drug Administration (FDA) has confirmed receipt of the change of ownership letters formally transferring ownership of the 23 generic drug products to IDT.
Cipher Pharmaceuticals Inc. announced it has acquired INNOCUTIS Holdings LLC, a privately held specialty dermatology company, for $45.5 million in cash.
North Dakota's Legislature has passed a measure that gives patients the chance to try experimental drugs that haven't gotten final approval for general use from the U.S. Food and Drug Administration.
The companies said the acquisition creates a top-tiered global OTC pharmaceutical and nutraceutical company.
Roche has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans.
Many so-called cancer hotels dot the neighborhoods around Chinese hospitals, giving patients an affordable, cozy place to wait for appointments and undergo outpatient treatment.
Underlining a change across the nation, nearly 9 out of 10 adults now say they have health insurance, according to an extensive survey released Monday.
The Material Master system utilizes "v-shaped" tubular breaker profiles to efficiently return even the most severely agglomerated materials to a free-flowing state.
Sartorius Stedim Biotech, a global supplier of the biopharmaceutical industry, has launched a new version of its proven stainless steel fermentor/bioreactor BIOSTAT D-DCU.
Neothetics initiated Phase 3 trials of a non-invasive injectable for reduction of central abdominal bulging due to subcutaneous fat.
AstraZeneca and PatientsLikeMe have signed a five-year agreement to provide access to PatientsLikeMe’s global network in support of AstraZeneca’s patient-driven research initiatives.
Merck is introducing Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.
Volkmann has designed and manufactured a line of vacuum conveyors to meet the specific needs of the pharmaceutical industry.